We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.11B
AUM Growth
+$508M
Cap. Flow
+$71.5M
Cap. Flow %
1.4%
Top 10 Hldgs %
29.75%
Holding
158
New
25
Increased
53
Reduced
18
Closed
16

Top Buys

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$46M
2
ANNX icon
Annexon
ANNX
+$41.6M
3
CTAS icon
Cintas
CTAS
+$41M
4
GTM
ZoomInfo Technologies
GTM
+$40.9M
5
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
+$39.2M

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$53.4M
2
LII icon
Lennox International
LII
+$42.7M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$40.3M
4
SPLK
Splunk Inc
SPLK
+$39.6M
5
ZGNX
Zogenix, Inc.
ZGNX
+$32.7M

Sector Composition

Rank Sector Weight
1 Healthcare 40.89%
2 Technology 24.02%
3 Industrials 10.32%
4 Consumer Discretionary 8.24%
5 Communication Services 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASML icon
26
ASML
ASML
$634B
$63.5M 1.24%
172,000
– –
TREX icon
27
Trex
TREX
$4.56B
$63.2M 1.24%
882,000
+134,000
+18% +$9.27M
VRSK icon
28
Verisk Analytics
VRSK
$26.1B
$61.8M 1.21%
333,400
+113,900
+52% +$20.9M
PLRX icon
29
Pliant Therapeutics
PLRX
$65.6M
$61.7M 1.21%
2,838,125
– –
DHI icon
30
D.R. Horton
DHI
$40.7B
$54.4M 1.07%
719,600
-10,600
-1% -$724K
ANNX icon
31
Annexon
ANNX
$863M
$52.4M 1.03%
+1,773,111
New +$41.6M
IPHI
32
DELISTED
INPHI CORPORATION
IPHI
$51M 1%
454,378
+4,378
+1% +$511K
COLL icon
33
Collegium Pharmaceutical
COLL
$1.17B
$50.5M 0.99%
2,427,976
– –
MRTX
34
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$50M 0.98%
301,000
– –
APTV icon
35
Aptiv
APTV
$12.3B
$49.2M 0.96%
537,000
– –
BEP icon
36
Brookfield Renewable
BEP
$9.9B
$46.6M 0.91%
1,330,950
-388,299
-23% -$11.5M
ECL icon
37
Ecolab
ECL
$78.6B
$46M 0.9%
+230,000
New +$46M
TRIL
38
DELISTED
Trillium Therapeutics Inc.
TRIL
$45.4M 0.89%
3,197,008
+650,008
+26% +$6.48M
CCI icon
39
Crown Castle
CCI
$33.4B
$45.2M 0.88%
271,300
+7,900
+3% +$1.3M
GTM
40
ZoomInfo Technologies
GTM
$978M
$44.9M 0.88%
+1,044,018
New +$40.9M
CTAS icon
41
Cintas
CTAS
$82.7B
$44.3M 0.87%
+532,000
New +$41M
RNG icon
42
RingCentral
RNG
$4.48B
$43.8M 0.86%
159,349
+4,349
+3% +$1.21M
BPMC
43
DELISTED
Blueprint Medicines
BPMC
$42.8M 0.84%
462,000
– –
GWPH
44
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$42.4M 0.83%
436,000
– –
ARGX icon
45
argenx
ARGX
$54.6B
$42M 0.82%
160,000
-104,000
-39% -$25M
SPT icon
46
Sprout Social
SPT
$509M
$37.7M 0.74%
+980,007
New +$31.1M
MGA icon
47
Magna International
MGA
$19B
$36.3M 0.71%
793,100
+58,400
+8% +$2.81M
FRLN
48
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$35.6M 0.7%
+156,220
New +$39.2M
PANW icon
49
Palo Alto Networks
PANW
$265B
$35.6M 0.7%
871,812
+20,790
+2% +$865K
RCKT icon
50
Rocket Pharmaceuticals
RCKT
$351M
$35.4M 0.69%
1,550,000
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Eventide Asset Management held 158 positions worth $5.11B, up 11% from $4.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Eventide Asset Management's Q3 2020 filing shows 25 new, 53 increased, 18 reduced and 16 closed positions. Its largest new stake was Ecolab: 230,000 shares worth $46M. The largest sale was Aimmune Therapeutics, an estimated $53.4M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 45% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q3 2020 buy was Ecolab: 230,000 shares worth $46M.
  • Eventide Asset Management added most to Dynatrace in Q3 2020, an estimated $32.6M increase.
  • Eventide Asset Management's biggest Q3 2020 reduction was Lennox International, cutting an estimated $42.7M.
  • Eventide Asset Management fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $53.4M.
  • Eventide Asset Management's ten largest holdings make up 30% of its $5.11B portfolio in Q3 2020.
  • Eventide Asset Management opened 25 new positions and closed 16 in Q3 2020.
  • Eventide Asset Management's portfolio value rose 11% quarter-over-quarter to $5.11B.

Based on Eventide Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.